A rapid and sensitive LC–MS/MS method for determination of lercanidipine in human plasma and its application in a bioequivalence study in Chinese healthy volunteers

2016 ◽  
Vol 128 ◽  
pp. 67-72 ◽  
Author(s):  
Xiaobing Li ◽  
Fuguo Shi ◽  
Xiaojing He ◽  
Lingyan Jian ◽  
Li Ding
2015 ◽  
Vol 29 (10) ◽  
pp. 1506-1513 ◽  
Author(s):  
Jialang Zhuang ◽  
Jiangying Chen ◽  
Xueding Wang ◽  
Yin Pang ◽  
Huichang Bi ◽  
...  

2011 ◽  
Vol 02 (04) ◽  
pp. 341-346 ◽  
Author(s):  
Dujuan Zhang ◽  
Jing Zhang ◽  
Xiaoyan Liu ◽  
Chunmin Wei ◽  
Rui Zhang ◽  
...  

Bioanalysis ◽  
2021 ◽  
Author(s):  
Gabriel Onn Kit Loh ◽  
Emily Yii Ling Wong ◽  
Yvonne Tze Fung Tan ◽  
Yi Lin Lee ◽  
Chun Keat Chew ◽  
...  

Aim: To develop an LC-MS/MS method for simultaneous determination of duloxetine and its metabolite, 4-hydroxy duloxetine glucuronide (4HDG) in human plasma and to investigate the potential back-conversion of 4HDG to duloxetine using stability study. Materials & methods: The LC-MS/MS method was validated according to the EMA and USFDA Bioanalytical Method Validation Guidelines and applied to pilot bioequivalence study. Results & conclusion: The method validation results were within the acceptance limits. The stability study and incurred sample reanalysis results ruled out the occurrence of back-conversion. The study highlighted the conduct of back-conversion test and the advantages of LC-MS/MS method in terms of sensitivity, specificity and low consumption of organic solvents.


Sign in / Sign up

Export Citation Format

Share Document